Amgen Inc. (AMGN) News
Filter AMGN News Items
AMGN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AMGN News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest AMGN News From Around the Web
Below are the latest news stories about AMGEN INC that investors may wish to consider to help them evaluate AMGN as an investment opportunity.
Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 January 13, 2025 06:00 PM ET Company Participants Robert Bradway - Chairman, CEO & President Conference Call Participants Chris Schott - JPMorgan Presentation Chris Schott Good afternoon, everybody. I'm Chris Schott from JPMorgan, and it's or -- good afternoon. It's my pleasure to be introducing Amgen today. From Amgen, we have the company's chairman and CEO, Bob Bradway. Bob, happy New Year. Thanks for joining us, and look forward to your presentation as we think about Amgen heading into 2025. Robert Bradway Okay. Thank you, Chris. Okay. Good afternoon, everyon... |
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second presidency. |
Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss DrugThe initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill lost up to 8.2% in body weight after 28 days. |
AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEAmgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday, January 13, 2025. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. |
Amgen (AMGN) Advances While Market Declines: Some Information for InvestorsAmgen (AMGN) closed at $262.05 in the latest trading session, marking a +1.34% move from the prior day. |
How to Find Strong Medical Stocks Slated for Positive Earnings SurprisesWhy investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. |
The Zacks Analyst Blog Highlights Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONARMicrosoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR are part of the Zacks top Analyst Blog. |
Amgen (AMGN) Stock Sinks As Market Gains: Here's WhyAmgen (AMGN) concluded the recent trading session at $258.59, signifying a -1.01% move from its prior day's close. |
Top Analyst Reports for Microsoft, Exxon Mobil & AmgenToday's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Exxon Mobil Corporation (XOM) and Amgen Inc. (AMGN), as well as two micro-cap stocks PrimeEnergy Resources Corporation (PNRG) and FONAR Corporation (FONR). |
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |